Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than ...